Related Experiment Video

Updated: Aug 29, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in

Robert I Nicholson1, Iain R Hutcheson, Janice M Knowlden

  • 1Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, Wales, United Kingdom. nicholsonri@cf.ac.uk

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 22, 2004
PubMed

Insights

Growth factor signaling interacts with estrogen receptor signaling in breast cancer. Targeting growth factors can overcome antiestrogen resistance and improve breast cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Estrogen receptor (ER) signaling is a key driver of breast cancer growth.
  • Growth factor networks are increasingly recognized for their interaction with ER signaling.
  • Dysregulation in growth factor pathways can lead to resistance to antiestrogen therapies.

Purpose of the Study:

  • To illustrate the interplay between growth factor signaling and antiestrogen therapy failure in breast cancer models.
  • To describe novel strategies targeting growth factor activity to enhance antiestrogen efficacy.
  • To investigate methods for blocking aggressive breast cancer progression.

Main Methods:

  • Utilized in-house tumor models of breast cancer.
  • Investigated the relationship between growth factor signaling pathways and antiestrogen response.
  • Developed and tested therapeutic strategies targeting growth factor activity.

Main Results:

  • Demonstrated a significant interaction between growth factor networks and estrogen receptor signaling in breast cancer.
  • Identified alterations in growth factor signaling as a mechanism for developing antiestrogen resistance.
  • Showcased the successful targeting of growth factor activity to improve antiestrogen drug effects.

Conclusions:

  • Growth factor signaling plays a critical role in breast cancer progression and response to antiestrogen therapy.
  • Targeting growth factor pathways represents a promising strategy to overcome antiestrogen resistance.
  • Interventions aimed at growth factor activity can improve treatment outcomes and impede aggressive disease progression.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...